Immatics N.V. (IMTX)
NASDAQ: IMTX · Real-Time Price · USD
6.03
+0.03 (0.50%)
At close: Sep 17, 2025, 4:00 PM EDT
6.17
+0.14 (2.32%)
After-hours: Sep 17, 2025, 7:45 PM EDT
Immatics Market Cap
Immatics has a market cap or net worth of $733.00 million as of September 17, 2025. Its market cap has decreased by -35.84% in one year.
Market Cap
733.00M
Enterprise Value
191.52M
1-Year Change
-35.84%
Ranking
Category
Stock Price
$6.03
Market Cap Chart
Since December 12, 2018, Immatics's market cap has increased from $172.50M to $733.00M, an increase of 324.93%. That is a compound annual growth rate of 23.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 729.36M | -14.05% |
| Dec 31, 2024 | 848.62M | -4.80% |
| Dec 29, 2023 | 891.43M | 34.26% |
| Dec 30, 2022 | 663.94M | -21.47% |
| Dec 31, 2021 | 845.50M | 24.56% |
| Dec 31, 2020 | 678.78M | 263.23% |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 686.51B |
| Johnson & Johnson | 424.98B |
| AbbVie | 382.04B |
| UnitedHealth Group | 307.73B |
| Novo Nordisk | 253.09B |
| AstraZeneca | 240.11B |
| Novartis AG | 237.94B |
| Abbott Laboratories | 231.06B |